Charles Franklin Hoover
Charles Franklin Hoover (1865–1927) was an American neurologist known for his work in the field of neurology. He is best remembered for describing Hoover's sign, a clinical sign used in the diagnosis of functional neurological disorder.
Early Life and Education[edit]
Charles Franklin Hoover was born in 1865 in America. He pursued his medical education from a reputed medical school, where he developed a keen interest in neurology.
Career[edit]
Hoover started his career as a physician and later specialized in neurology. He made significant contributions to the field, particularly in the diagnosis and treatment of neurological disorders. His work was widely recognized and appreciated by his peers and the medical community.
Hoover's Sign[edit]
Hoover's sign is a clinical sign used in the diagnosis of functional neurological disorder. It was first described by Hoover in 1908. The sign is used to differentiate between organic and functional paralysis. When a patient with suspected functional paralysis is asked to lift the "paralyzed" leg, the contralateral leg pushes down on the examination table. This is considered a positive Hoover's sign and suggests a functional, rather than organic, cause of the paralysis.
Legacy[edit]
Hoover's contributions to neurology, particularly his description of Hoover's sign, continue to be used in clinical practice today. His work has had a lasting impact on the field and he is remembered as a pioneer in neurology.
See Also[edit]
References[edit]
- Hoover CF. A new sign for the detection of malingering and functional paresis of the lower extremities. JAMA. 1908;L(15):1118–1121.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian